Australian Approved Name
Australian Approved Name (AAN)
Australian Approved Name (pronunciation: /ɔːˈstreɪliən əˈpruːvd neɪm/) is a term used in the field of Pharmacology and Drug Regulation in Australia. It refers to the official, non-proprietary or generic name given to a pharmaceutical substance or active pharmaceutical ingredient (API) by the Therapeutic Goods Administration (TGA) in Australia.
Etymology
The term "Australian Approved Name" is derived from its function. It is a name that has been approved by the relevant Australian authorities for use in relation to a specific pharmaceutical substance.
Related Terms
- Active Pharmaceutical Ingredient (API): This is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
- Therapeutic Goods Administration (TGA): This is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. It is a division of the Australian Department of Health established under the Therapeutic Goods Act 1989.
- Pharmacology: This is the branch of medicine that deals with the uses, effects, and modes of action of drugs.
- Drug Regulation: This refers to the control exercised over drug manufacture, sale, and distribution by various government and non-governmental agencies.
See Also
External links
- Medical encyclopedia article on Australian Approved Name
- Wikipedia's article - Australian Approved Name
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski